跳至主要内容
临床试验/NCT05210114
NCT05210114招募中不适用

Cutaneous Hydration Assessment in Sickle Cell Disease

Enrico Novelli2 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2022年1月21日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
30
试验地点
2
主要终点
Dermal water content measurements before fluid resuscitation in SCD participants with VOC or VOE

研究概览

简要总结

This study will validate the diagnostic accuracy of a cutaneous hydration sensor. This sensor will also be evaluated for its feasibility as a point-of-care device for the assessment of hydration status and its potential to guide hydration therapy in patients with sickle cell disease (SCD).

详细描述

Vaso-occlusive episodes (VOE) are the leading cause of hospitalization for patients with SCD. Intravenous fluid replacement is one of the cornerstones of management of VOE in the emergency department and throughout hospitalization. However, there are no evidence-based guidelines specifying the optimal administration of maintenance fluids. Overly aggressive hydration therapy imparts the risk of hypervolemia and pulmonary edema, which may lead to acute chest syndrome and death. Thus, a reliable biomarker is needed to gauge hydration status and guide fluid replacement strategies with the goal of achieving euvolemia.

The investigators propose a point-of-care test that may inform management (e.g., bolus vs. continuous infusion of maintenance intravenous fluid), and prevent over- or under-hydration. For this purpose, investigators seek to validate the diagnostic accuracy of a cutaneous hydration sensor, Delfin MoistureMeterEpiD (a non-significant risk device) and evaluate its feasibility as a point-of-care device for the assessment of hydration status and potentially guide hydration therapy in patients with SCD. Investigators will measure skin hydration in the clinic when participants are at baseline state of health. Skin hydration before and after fluid resuscitation therapy in patients with vaso-occlusive crisis (VOC) or VOE will also be assessed. Blood and urine will be collected to compare assessments of skin hydration with laboratory biomarkers of hypertonicity and red blood cell dehydration.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
12 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of Sickle Cell Disease (genotypes SS, SC, Sß-thalassemia, SD, SOArab)
  • Participants must be ≥12-years old
  • Participants that provide legally effective consent to all study procedures

排除标准

  • Participants under 12-years old
  • Participants being treated with experimental therapies in clinical trials

结局指标

主要结局

Dermal water content measurements before fluid resuscitation in SCD participants with VOC or VOE

时间窗: During a VOC or VOE event before IV fluid resuscitation, approximately 2 hours

Delfin MoistureMeterEpiD hydration sensor will be used to measure dermal water content in 10 participants.

Dermal water content measurements in SCD participants at baseline state of health

时间窗: During a regularly scheduled clinic appointment, approximately 2 hours

Delfin MoistureMeterEpiD hydration sensor will be used to measure dermal water content in 20 participants at 1 time point.

Clinical dehydration assessments in SCD participants

时间窗: At a regularly scheduled clinical appointment, approximately 2 hours

Clinical assessment of dehydration will be ascertained by administering the 10-point Clinical Dehydration Scale (CDS). CDS uses clinical characteristics (general appearance, eyes, mucous membranes, and tears), each of which are scored 0, 1, or 2 for a total score of 0 to 8, with 0 representing no dehydration; 1 to 4, some dehydration; and 5 to 8, moderate/severe dehydration. It will be administered at 1 time point in 20 participants.

Measurement of hyperadhesion as a laboratory biomarker of dehydration in SCD participants

时间窗: At a regularly scheduled clinical appointment, approximately 2 hours

As a marker of hyperadhesion capillary transit time will be measured using capillary mimicking microfluidic channels. It will be measured at 1 timepoint in 20 participants.

Measurement of urine osmolality as a laboratory biomarker of dehydration in SCD participants

时间窗: At a regularly scheduled clinical appointment, approximately 2 hours

Urine osmolality values \<450 milliosmol/kg is considered abnormal in adults without fluid restrictions. It will be measured at 1 timepoint in 20 participants.

Measurement of point of sickling as a cellular biomarker of dehydration before fluid resuscitation therapy in SCD participants with VOC or VOE

时间窗: During a VOC or VOE event before fluid resuscitation therapy, approximately 2 hours

Cellular dehydration marker, the elongation index will be measured by ektacytometry. It will be measured at 1 timepoint in 10 participants.

Measurement of serum osmolality as a laboratory biomarker of dehydration before resuscitation therapy in SCD participants with VOC or VOE

时间窗: During a VOC or VOE event before resuscitation therapy, approximately 2 hours

Serum osmolality values of \>290 milliosmol/kg is considered abnormal. It will be measured at 1 timepoint in 10 participants.

Measurement of hyperadhesion as a laboratory biomarker of dehydration before fluid resuscitation therapy in SCD participants with VOC or VOE

时间窗: During a VOC or VOE event before fluid resuscitation therapy, approximately 2 hours

As a marker of hyperadhesion, capillary transit time will be measured using capillary mimicking microfluidic channels. It will be measured at 1 timepoint in 10 participants.

Dermal water content measurements after fluid resuscitation in SCD participants with VOC or VOE

时间窗: During a VOC or VOE event after IV fluid resuscitation, approximately 2 hours

Delfin MoistureMeterEpiD hydration sensor will be used to measure dermal water content in 10 participants.

Measurement of serum osmolality as a laboratory biomarker of dehydration in SCD participants

时间窗: At a regularly scheduled clinical appointment, approximately 2 hours

Serum osmolality values of \>290 milliosmol/kg is considered abnormal. It will be measured at 1 timepoint in 20 participants.

Measurement of elongation index as a cellular biomarker of dehydration in SCD participants

时间窗: At a regularly scheduled clinical appointment, approximately 2 hours

Cellular dehydration marker, the elongation index, will be measured by ektacytometry. It will be measured at 1 timepoint in 20 participants.

Measurement of point of sickling as a biomarker of dehydration in SCD participants

时间窗: At a regularly scheduled clinical appointment, approximately 2 hours

Point of sickling, a cellular dehydration biomarker, will be measured by ektacytometry. It will be measured at 1 timepoint in 20 participants.

Measurement of urine osmolality as laboratory biomarkers of dehydration after fluid resuscitation therapy in SCD participants with VOC or VOE

时间窗: During a VOC or VOE event after fluid resuscitation therapy, approximately 2 hours

Urine osmolality values \<450 milliosmol/kg is considered abnormal in adults without fluid restrictions. It will be measured at 1 timepoint in 10 participants.

Measurement of serum osmolality as a laboratory biomarker of dehydration after fluid resuscitation therapy in SCD participants with VOC or VOE

时间窗: During a VOC or VOE event after fluid resuscitation therapy, approximately 2 hours

Serum osmolality values of \>290 milliosmol/kg is considered abnormal. It will be measured at 1 timepoint in 10 participants.

Measurement of elongation index as a cellular biomarker of dehydration after fluid resuscitation therapy in SCD participants with VOC or VOE

时间窗: During a VOC or VOE event after fluid resuscitation therapy, approximately 2 hours

Cellular dehydration marker, the elongation index will be measured by ektacytometry. It will be measured at 1 timepoint in 10 participants.

Measurement of urine osmolality as laboratory biomarkers of dehydration before fluid resuscitation therapy in SCD participants with VOC or VOE

时间窗: During a VOC or VOE event before fluid resuscitation therapy, approximately 2 hours

Urine osmolality values \<450 milliosmol/kg is considered abnormal in adults without fluid restrictions. It will be measured at 1 timepoint in 10 participants.

Measurement of point of sickling as a cellular biomarker of dehydration after fluid resuscitation therapy in SCD participants with VOC or VOE

时间窗: During a VOC or VOE event after fluid resuscitation therapy, approximately 2 hours

Cellular dehydration marker, the elongation index will be measured by ektacytometry. It will be measured at 1 timepoint in 10 participants.

Measurement of hyperadhesion as a laboratory biomarker of dehydration after fluid resuscitation therapy in SCD participants with VOC or VOE

时间窗: During a VOC or VOE event after fluid resuscitation therapy, approximately 2 hours

As a marker of hyperadhesion, capillary transit time will be measured using capillary mimicking microfluidic channels. It will be measured at 1 timepoint in 10 participants.

Measurement of elongation index as a cellular biomarker of dehydration before resuscitation therapy in SCD participants with VOC or VOE

时间窗: During a VOC or VOE event before fluid resuscitation, approximately 2 hours

Cellular dehydration marker, the elongation index, will be measured by ektacytometry. It will be measured at 1 timepoint in 10 participants.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Enrico Novelli

Associate Professor and Section Chief - Classical Hematology

University of Pittsburgh

研究点 (2)

Loading locations...

相似试验